Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers: Guidance for Industry and Review Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 13, 2018
November 12, 2024
fef61098-3bf5-4dc1-8f77-41453aebdc3c
Related Documents
Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers : Guidance for Industry
Guidance DocumentJune 13, 2018Center for Drug Evaluation and Research
Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
Guidance DocumentMay 11, 2020Center for Drug Evaluation and Research
Tropical Disease Priority Review Vouchers
Guidance DocumentOctober 6, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox